"To date, Kechuang Bio has been very determined to follow the path of independent research and development, and its profit mainly comes from its core endorphins and brain-computer interfaces."

Taking these two products as examples, we won't discuss how much money was made, because that's clearly stated in Kechuang Bio's financial report. Instead, we'll discuss why technological innovation can create wealth.

Technological innovation can create demand, like the internet boom of recent years.

Are computers necessities? For people today, there's no doubt that computers are indispensable, whether for individuals or businesses. They are not only productivity tools but also personal entertainment devices.

The rapid development of computer technology has created a demand for computers, allowing everyone to enjoy and obtain the experiences they desire.

The same is true for the mobile internet over the past decade. Advances in communication technology and semiconductors have enabled most of the entertainment functions of computers to be integrated into mobile phones.

Furthermore, mobile devices can perform more unique functions than computers, such as ride-hailing and mobile payment, which are unique to mobile phones.

Technological advancements bring new demands, and this is also true for Kechuang Biotechnology.

Before the large-scale production of endorphins, morphine-based drugs dominated the market for analgesics. Now, endorphins are used extensively, and the more advanced the surgery, the more endorphins are needed.

If endorphins are high-end alternatives to existing demands, then brain-computer interfaces are a demand entirely created by innovative biotechnology.

Previously, brain-computer interface control of mobile phones was only a media publicity and a public imagination, and many users even doubted the necessity of brain-computer interface control of mobile phones.

Today, almost all high-end mobile phones in China and America are equipped with brain-computer interface functionality.

Users will automatically develop a psychological suggestion that a phone without brain-computer interface is not a high-end phone.

This also falls under the category of created needs.

Therefore, I personally believe that the top technology companies are those that can create demand, and the first-class companies are those that can meet demand. If you want to become a giant, you have to be able to create demand.

Kechuang Bio's corporate vision is not just to become a giant, which we have already achieved. Our longer-term corporate vision is to meet demand.

This is what Mr. Cheng said during our training after we were recruited from universities. I personally believe that we need to create more demand.

Finally, I'd like to mention that Kechuang Biotechnology seems to be recruiting on campus this spring. If you're interested, you can contact me, and I can refer you.

As a new company, Kechuang Bio has recruited a significant number of people through both campus recruitment and social recruitment in recent years.

Of course, the requirements are also very high, so it is difficult to recruit people.

If the referral is successful, the referrer will receive a generous bonus.

This is somewhat similar to employees at large internet companies like Alibaba and Tencent, who can earn hundreds of thousands of yuan in referral bonuses by helping others make internal referrals for over a year. This bonus is even linked to performance evaluations.

"Thank you for the invitation. Kechuang Bio's financial report proves one thing: it has deep pockets."

They clearly have plenty of money, and this year they still have revenue from brain-computer interface VR and lithium batteries waiting to be released.

Actually, a large portion of the profit comes from brain-computer interface prosthetics. I visited Luckin Coffee's cyberpunk-themed coffee shop last time, and the brain-computer interface robotic arms made by Kechuang Bio were really well-made.

I noticed that the latte art created by the disabled barista was just as exquisite as that of an able-bodied person; it might be a deliberate display of skill. Luckin Coffee's regular stores don't offer latte art at all. However, at their cyberpunk-themed coffee shop, latte art incurs an extra 10 yuan service charge.

This area, if intended to generate revenue, could be just as profitable as endorphin therapy. However, executives at Kechuang Biotechnology claim they will not profit from this technology and will instead offer it to consumers at the lowest possible price; therefore, this aspect has not been included in future revenue projections.

All I can say is that Chairman Zheng has a very broad vision.

The biggest focus this year will be on the revenue generated by the lithium battery sector. After all, the A-share lithium battery sector has already reacted so dramatically in advance; the last time the lithium battery sector experienced such a surge was in 2021.

The reactions on Zhihu were mostly optimistic, and the same was true within Kechuang Bio, because these were indeed monopolistic products, which in a sense were also core needs.

“Chairman Zheng, we are collecting rare plants from all over the world through various means, and these are the first batch of goods.”

Ignoring the outside noise, Zheng Li used the channels of Kechuang Biotechnology to collect various plants all over the world.

Since it does not require the plant to be alive, even a leaf from a rare plant is acceptable as long as the leaf still retains cell activity.

Therefore, the collection process is not slow.

After watching the goods being delivered to his laboratory on the seventeenth floor by the staff, Zheng Li went downstairs to take a look around the public experimental area during the delivery process.

"Wan Qing, how's the brain-computer interface prosthetic limb experiment going?"

Li Wanqing is very glad that he chose to come to Kechuang Biotechnology. The research team he manages has grown from less than 100 people to more than 1,000 people.

If they were to recruit a new R&D manager now, he definitely wouldn't be the one.

That's often how it is; even if you have better qualifications, if your position is taken, it's almost impossible to replace someone else.

One radish, one hole.

You can't pull out other radishes.

This is why academia is becoming increasingly competitive, because there are only so many openings, and the number of PhDs is increasing, so the openings are already filled, and the number of new openings is far outpaced by the expansion of the number of PhDs.

This is true in China, and it's also true in Europe and America. Ivy League PhDs can only get tenure-track positions at US universities ranked outside the top 50. That means US PhDs ranked outside the top 50 have to go to universities ranked outside the top 200.

My dear reader, there's more to this chapter! Please click the next page to continue reading—even more exciting content awaits!